Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : DRKOOP.Com,Inc - (Nasdaq - KOOP) -- Ignore unavailable to you. Want to Upgrade?

To: Mohan Marette who wrote (11)	5/16/1999 11:30:00 AM
From: Hans U. Tschanz	Respond to of 595

Some additional information from WSJ: One medical stock you may want to steer clear of is Healtheon, a firm that's trying to apply Internet technology to doctor's bills and records. Right now, such records stills reside largely on paper, or in comparably antique mainframe computers. No matter that Healtheon posted a loss of $18.6 million on $17.6 million of revenues in this year's first quarter. This is an Internet stock, and that is apparently enough to have sent its shares from an initial public offering price of $8 in February to a recent $47, making for a stock-market value of $2.9 billion. That price may seem steep for a firm that acknowledges its revenues still come mainly from its non-Internet claims-processing network and from work done for related parties, but the price was even steeper when the shares breached $61. It will be interesting to see how Healtheon can bring on low-cost Internet processing without undercutting the revenues it now gets the old-fashioned way. Investors may soon get the opportunity to invest in other new Internet-related medical companies such as DrKoop.com and MedScape (see story ). But for Salomon Smith Barney's Kolbert, the best health-care holdings are still the familiar ones, including Pfizer, Bristol-Myers Squibb, Lilly and Medtronic. Initial public offerings by medical firms have been rare sightings this year. Those of recent years have tended to be service stocks in fields such as physician practice management, an industry that has fallen on hard times. The practice-management industry tried to roll up local medical practice into national chains like PhyCor, with the aim of profiting from centralized office management and collective bargaining with health insurers. Bankruptcy proceedings of firms like MedPartners, however, show that the economic rationale of practice management remains unproven. In retrospect, the phenomenon seems to have been driven by deal-hungry investment bankers and doctors eager to cash out of a private business that faces increasing price pressure from HMOs and the federal government.

To: Mohan Marette who wrote (11)	5/18/1999 8:30:00 AM
From: Chas	Read Replies (2) \| Respond to of 595

So, I read the filing amendment and it estimates if its price is set at $8 the net value to the shareholder is around $5.33 or so. since the company has not made any money to date, how do you see this company ever really gaining any value providing free medical information. I can get sometimes better info on yahoo? In other words if I buy some shares at $9 or so, in one year from now, what would make the stock go up to get a decent return? Any estimate on what it will do the first day? Good trading,